deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01018095

Trichomonas Vaginalis Recurrence Among HIV+ Women

Randomized Phase IV Trial of Metronidazole Single Dose Versus 7 Day Dose for Treatment of Trichomonas Vaginalis Among HIV-infected Women

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Trichomonas Infections
Interventions Metronidazole
Updated 8 times since 2017 Last updated: Dec 16, 2016 Started: May 31, 2005 Primary completion: Jul 31, 2009 Completion: Aug 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates HIV Infections and Trichomonas Infections and is currently completed. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 3 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  3. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Tulane University Health Sciences Center
Data source: Tulane University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations